Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815106) titled 'OPtimization of Antiplatelet Therapy After the intervenTION of de Novo Coronary Artery Lesions With Drug-Coated Balloons' on Sept. 5.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Shanghai Zhongshan Hospital
Condition:
Chronic Coronary Syndrome
Intervention:
Drug: 1-month DAPT
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: October 1, 2026
Target Sample Size: 2122
To know more, visit https://clinicaltrials.gov/study/NCT07815106
Published by H...